Cancer Survival Analysis
Targeted Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 8, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Michael Augustin1, Kelsey Lyons2, Hayeon Kim3
1Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY.
Artificial intelligence (AI) shows superior prognostication for nonsmall cell lung cancer (NSCLC) compared to traditional methods. Deep learning (DL) algorithms outperform machine learning (ML), offering potential for personalized cancer therapy.
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: